Synthesis and structural characterization of novel bridged platinum(II) biscarbene complexes

Novel bridged platinum(II) biscarbene complexes are reported: 1,1′-dimethyl-3,3′-methylene-4-diimidazolin-2,2′-diylidene platinum(II) (3) and 1,1′-dimethyl-3,3′-ethylene-4-diimidazolin-2,2′-diylidene platinum(II) complexes 4 are directly accessible in high yields starting from platinum halides. The one-pot synthesis obviates the need for multi-step reactions via metal precursors or free carbenes. An X-ray crystal structure of 1,1′-dimethyl-3,3′-methylene-4-diimidazolin-2,2′-diylidene platinum(II) dibromide (3b) confirmed the structural similarity to the known corresponding palladium complexes. Since free 1,1′-di-R-3,3′-methylene-4-diimidazolin-2,2′-diylidenes are only available in low yields this synthetic route provides an easy access to the corresponding carbene complexes.     

Syntheses, crystal structure and spectroscopic characterization of new platinum(II) dithiocarbimato complexes

The reaction of 4-iodobenzenesulfonamide or 4-fluorobenzenesulfonamide with CS₂ and KOH in dimethylformamide yielded the potassium N-R-sulfonyldithiocarbimates, K₂(RSO₂NCS₂) [R = 4-IC₆H₄ (1) and 4-FC₆H₄ (2)]. These salts reacted with K₂[PtCl₄] in water/methanol to yield complex anions bis(N-R-sulfonyldithiocarbimato)platinate(II), which were isolated as their tetrabutylammonium salts, (Bu₄N)₂[Pt(RSO₂NCS₂)₂] [R = 4-IC₆H₄ (3) and 4-FC₆H₄ (4)]. The structures of 2–4 were determined by X-ray crystallography. The Pt²⁺ in both complexes 3 and 4 lies at the inversion centre and the PtS₄ moiety has a distorted square-planar configuration. The compounds were also characterized by IR, ¹H NMR and ¹³C NMR spectroscopies, and elemental analyses. The molar conductance data are consistent with the fact that 3 and 4 are dianionic complexes.     

Preparation,NMR studies and crystal structure of mononuclear and dinuclear Pd(II) and Pt(II) complexes that contain 1,2-bis[3-(3,5-dimethyl-1-pyrazolyl)-2-thiapropyl]benzene

The reaction between 1,2-bis[3-(3,5-dimethyl-1-pyrazolyl)-2-thiapropyl]benzene (bddf) and [MCl₂(CH₃CN)₂] (M = Pd(II), Pt(II)) in a 1:1 M/L ratio in CH₂Cl₂ or acetonitrile solution, respectively, gave the complexes trans-[MCl₂(bddf)] (M = Pd(II) (1), Pt(II) (4)), and in a 2:1 M/L ratio led to [M₂Cl₄(bddf)] (M = Pd(II) (2), Pt(II) (5)). Treatment of 1 and 4 with AgBF₄ and NaBPh₄, respectively, gave the compounds [Pd(bddf)](BF₄)₂ (3) and [Pt(bddf)](BPh₄)₂ (6). When complexes 3 and 6 were heated under reflux in a solution of Et₄NBr in CH₂Cl₂/CH₃OH (1:1) for 24 h, analogous complexes to 1 and 4 with bromides instead of chlorides bonded to the metallic centre were obtained. These complexes were characterised by elemental analyses, conductivity measurements, infrared, ¹H, ¹H{¹⁹⁵Pt}, ¹³C{¹H}, ¹⁹⁵Pt{¹H} NMR, HSQC and NOESY spectroscopies. The X-ray crystal structure of the complex [Pd(bddf)](BF₄)₂ · H₂O has been determined. The metal atom is tetracoordinated by the two azine nitrogen atoms of the pyrazole rings and two thioether groups.     

Synthesis,structural characterization,molecular docking,and urease inhibition studies of dinuclear cobalt(II) complexes derived from 3,5-bis(pyridin-2-yl)-4-amino-1,2,4-triazole

Two dinuclear Co(II) complexes, [Co₂(L)₂(EtOH)₄]·4ClO₄ (1) and [Co₂(L)₂(H₂O)₂(NO₃)₂]·2NO₃ (2) (L?=?4-amino-3,5-bis(pyridin-2-yl)-1,2,4-triazole), have been obtained and characterized by IR, elemental analysis, and single-crystal X-ray diffraction analysis. The stabilization of their crystal lattices is maintained by strong H-bonds between counterions and host framework, which lead to various supramolecular architectures. The urease inhibitory properties of 1, 2, and L were investigated, where the two complexes revealed strong urease inhibition activities. Docking simulations of 2 have been performed with H. pylori urease (PDB code: 1E9Z) to rationalize their binding models.     

Platinum(II) complexes with bidentate iminopyridine ligands: Synthesis,spectral characterization,properties and structural analysis

Four platinum(II) complexes, [PtCl₂L] (L = (4-fluorophenyl)pyridin-2-ylmethylene-amine, 1; (4-chlorophenyl)pyridin-2-ylmethyleneamine, 2; (4-bromophenyl)pyridin-2-ylmethyleneamine, 3 and (4-iodophenyl)pyridin-2-ylmethyleneamine, 4) have been synthesized and characterized by CHN analysis, IR and UV–Vis spectroscopy. The crystal structures of 1 and 2 were determined using single crystal X-ray diffraction. The coordination polyhedron about the platinum (II) center in the complexes is best described as distorted square planar. The complexes undergo stacking to form a zigzag Pt···Pt···Pt chain containing both short (3.57(7) Å in 1 and 3.62(8) Å in 2) and long (5.16(7) Å in 1 and 5.41(9) Å in 2) Pt···Pt separations through the crystal. The compounds absorb moderately in the visible region, owing to a charge-transfer-to-diimine electronic transition. The redox potentials are approximately insensitive to the substituents on the phenyl ring of the ligands.     

Synthesis and characterization of new platinum(II) phosphinate complexes

The syntheses of platinum(II) complexes of bis(dimethylphosphinylmethylene)amine and bis(aminomethyl)phosphinic acid were investigated. In the case of bis(dimethyl-phosphinylmethylene)amine the reaction with K₂[PtCl₄] yields the potassium amino-trichloroplatinate K[PtCl₃L] (L?=?bis(dimethylphosphinylmethylene)amine), which was characterized by multinuclear (¹H, ¹³C, ³¹P, and ¹⁹⁵Pt) NMR spectroscopy in solution. Bis(aminomethyl)phosphinic acid reacts with K₂[PtCl₄] under strictly controlled pH conditions to give colorless crystals of the cisplatin analog K[PtCl₂L′] (L′?=?bis(aminomethyl)phosphinate). This complex was characterized by multinuclear NMR spectroscopy in solution as well as by single-crystal X-ray diffraction in the solid state. The bis(aminomethyl)phosphinate coordinates to platinum via both amino functions, thus acting as a chelating ligand.     

Synthesis, crystal structure and in vitro antitumor activity of carboxylate bridged dinuclear organotin(IV) complexes

Two novel dinuclear organotin(IV) complexes [n-Bu₂Sn(imda)(H₂O)]₂·Bipy (1) and [n-Bu₂Sn(imda)(H₂O)]₂·Phen (2) [H₂imda = iminodiacetic acid, Bipy = 2,2′-bipyridine and Phen = 1,10-phenanthroline] were synthesised and characterized employing IR, ¹H, ¹³C, ¹¹⁹Sn NMR, and ¹¹⁹Sn Mössbauer spectroscopic and elemental analyses. Single crystal X-ray crystallography of 1 has confirmed that it is a binuclear Sn(IV) species formed via carboxylate bridges where each metal adopted a seven coordinate distorted pentagonal bipyramidal geometry. The iminodiacetate dianion (imda²⁻) acts as a potential tridentate [N,O,O] carboxylate bridging ligand. The packing revealed that the additional α-diimine (Bipy or Phen) does not coordinate to metal ion. However, its presence in the crystal lattice as spacer helps for the formation of a supramolecular framework by bringing the two binuclear species close enough through extensive H-bonding. The in vitro cytotoxicity of compounds 1 and 2 indicate better results than cisplatin against three tumor cell lines investigated.     

Synthesis,characterization, crystal structure and antiproliferative activity of platinum(II) complexes with 2-acetylpyridine-4-cyclohexyl-thiosemicarbazone

New platinum complexes have been synthesized by the reaction of Na₂PtCl₄ with 2-acetylpyridine-4-cyclohexyl-thiosemicarbazone, HAc4CyclHexyl (1). The new complexes [Pt(Ac4CyclHexyl)Cl] (2) and [Pt(Ac4CyclHexyl)₂] (3) have been characterized by elemental analyses and spectroscopic studies. The crystal structure of the complex [Pt(Ac4CyclHexyl)Cl] · DMF has been solved by single-crystal X-ray diffraction. The anion of Ac4CyclHexyl coordinates in a planar conformation to the central platinum(II) through the pyridyl N, azomethine N and thiolato S atoms. The crystal packing is determined by double intermolecular hydrogen interactions, π–π, Pt–C and Pt–π contacts. The cytotoxic activities of 1–3 have been evaluated for antiproliferative activity in vitro against the cells of three human cancer cell lines: MCF-7 (human breast cancer cell line), T24 (bladder cancer cell line), A-549 (non-small cell lung carcinoma) and a mouse L-929 (a fibroblast-like cell line cloned from strain L). The compounds 1–3 display IC₅₀ values in a μM range better than that of the antitumor drug cisplatin and are considered as agents with potential antitumor activity candidates for further stages of screening in vitro and/or in vivo.     

Tuning the sulfur-heterometal interaction in organolead(IV) complexes of [Pt2(μ-S)2(PPh3)4]

Reactions of [Pt₂(μ-S)₂(PPh₃)₄] with Ph₃PbCl, Ph₂PbI₂, Ph₂PbBr₂ and Me₃PbOAc result in the formation of bright yellow to orange solutions containing the cations [Pt₂(μ-S)₂(PPh₃)₄PbR₃]⁺ (R₃ = Ph₃, Ph₂I, Ph₂Br, Me₃) isolated as PF₆⁻ or BPh₄⁻ salts. In the case of the Me₃Pb and Et₃Pb systems, a prolonged reaction time results in formation of the alkylated species [Pt₂(μ-S)(μ-SR)(PPh₃)₄]⁺ (R = Me, Et). X-ray structure determinations on [Pt₂(μ-S)₂(PPh₃)₄PbMe₃]PF₆ and [Pt₂(μ-S)₂(PPh₃)₄PbPh₂I]PF₆ have been carried out, revealing different coordination modes. In the Me₃Pb complex, the (four-coordinate) lead atom binds to a single sulfur atom, while in the Ph₂PbI adduct coordination of both sulfurs results in a five-coordinate lead centre. These differences are related to the electron density on the lead centre, and indicate that the interaction of the heterometal centre with the {Pt₂S₂} metalloligand core can be tuned by variation of the heteroatom substituents. The species [Pt₂(μ-S)₂(PPh₃)₄PbR₃]⁺ display differing fragmentation pathways in their ESI mass spectra, following initial loss of PPh₃ in all cases; for R = Ph, loss of PbPh₂ occurs, yielding [Pt₂(μ-S)₂(PPh₃)₃Ph]⁺, while for R = Me, reductive elimination of ethane gives [Pt₂(μ-S)₂(PPh₃)₃PbMe]⁺, which is followed by loss of CH₄.     

Interactions of nitrogen-donor bio-molecules with dinuclear platinum(II) complexes

Substitution reactions of the dinuclear Pt(II) complexes, [{Pt(en)Cl}₂(μ-pz)]²⁺ (1), [{Pt(dach)Cl}₂(μ-pz)]²⁺ (2) and [{Pt(dach)Cl}₂(μ-4,4?-bipy)]²⁺ (3), and corresponding aqua analogs with selected biologically important ligands, viz. 1,2,4-triazole, L-histidine (L-His) and guanosine-5?-monophosphate (5?-GMP) were studied under pseudo-first-order conditions as a function of concentration and temperature using UV–vis spectrophotometry. The reactions of the chloride complexes were followed in aqueous 25 mmol L^?1 Hepes buffer in the presence of 40 mmol L^?1 NaCl at pH 7.2, whereas the reactions of the aqua complexes were studied at pH 2.5. Two consecutive reaction steps, which both depend on the nucleophile concentration, were observed in all cases. The second-order rate constants for both reaction steps indicate a decrease in the order 1 > 2 > 3 for all complexes. Also, the pK_a values of all three aqua complexes were determined. The order of the reactivity of the studied ligands is 1,2,4-triazole > L-His > 5?-GMP. ¹H NMR spectroscopy and HPLC were used to follow the substitution of chloride in the dichloride 1, 2, and 3 complexes by guanosine-5?-monophosphate (5?-GMP). This study shows that the inert and bridging ligands have an important influence on the reactivity of the studied complexes.     

Pd(II) complexes of novel phosphine ligands: Synthesis,characterization, and catalytic activities on Heck reaction

Novel phosphine oxides, (((3-methylpyridin-2-yl)amino)methyl)diphenylphosphine oxide (1) and diphenyl((pyrazin-2-ylamino)methyl)phosphine oxide (2), were synthesized and characterized. Phosphines ligands (3 and 4) were obtained by the reduction of 1 and 2 with AlH₃, monitored by ³¹P NMR spectroscopy. Pd(II) complexes of 3 and 4 were synthesized and characterized (5 and 6). The catalytic activity of 5 and 6 was tested on the reaction of styrene with both activated and deactivated aryl bromides in air. The results of the catalytic experiments were discussed through DFT calculations.     

Titanium(IV) carboxylate complexes: Synthesis,structural characterization and cytotoxic activity

Four titanium(IV) carboxylate complexes [Ti(η⁵-C₅H₅)₂(O₂CCH₂SMes)₂] (1), [Ti(η⁵-C₅H₄Me)₂(O₂CCH₂SMes)₂] (2), [Ti(η⁵-C₅H₅)(η⁵-C₅H₄SiMe₃)(O₂CCH₂SMes)₂] (3) and [Ti(η⁵-C₅Me₅)(O₂CCH₂SMes)₃] (4; Mes = 2,4,6-Me₃C₆H₂) have been synthesised by the reaction of the corresponding titanium derivatives [Ti(η⁵-C₅H₅)₂Cl₂], [Ti(η⁵-C₅H₄Me)₂Cl₂], [Ti(η⁵-C₅H₅)(η⁵-C₅H₄SiMe₃)Cl₂] and [Ti(η⁵-C₅Me₅)Cl₃] and two (for 1–3) or three (for 4) equivalents of mesitylthioacetic acid. Complexes 1–4 have been characterized by spectroscopic methods and the molecular structure of the complexes 1, 2 and 4 have been determined by X-ray diffraction studies. The cytotoxic activity of 1–4 was tested against tumor cell lines human adenocarcinoma HeLa, human myelogenous leukemia K562, human malignant melanoma Fem-x, and normal immunocompetent cells, that is peripheral blood mononuclear cells PBMC and compared with those of the reference complexes [Ti(η⁵-C₅H₅)₂Cl₂] (R1), [Ti(η⁵-C₅H₄Me)₂Cl₂] (R2), [Ti(η⁵-C₅H₅)(η⁵-C₅H₄SiMe₃)Cl₂] (R3) and cisplatin. In all cases, the cytotoxic activity of the carboxylate derivatives was higher than that of their corresponding dichloride analogues, indicating a positive effect of the carboxylato ligand on the final anticancer activity. Complexes 1–4 are more active against K562 (IC₅₀ values from 72.2 to 87.9 μM) than against HeLa (IC₅₀ values from 107.2 to 142.2 μM) and Fem-x cells (IC₅₀ values from 90.2 to 191.4 μM).     

Synthesis and characterisation of the platinum complexes [PtCl(CClPAr)(PPh3)2] and [PtCl(CClPAr′)(PPh3)2] as potential intermediates in the preparation of phosphaalkynes

Oxidative addition reactions of Cl₂CPR (R = 2,4,6-tris(trifluoromethyl)phenyl (Ar) or 2,6-bis(trifluoromethyl)phenyl (Ar′) with Pt(PPh₃)₄ yield the cis and trans (at platinum) complexes [PtCl(ClCPAr)(PPh₃)₂] and [PtCl(ClCPAr′)(PPh₃)₂]. All starting materials and intermediates have been characterised by NMR spectroscopy. The crystal and molecular structures of the trans-platinum complexes have been determined by single-crystal X-ray diffraction at low temperature.     

Mono and dinuclear arene ruthenium complexes containing 6,7-dimethyl-2,3-di(pyridine-2-yl)quinoxaline as chelating ligand: Synthesis and molecular structure

The mononuclear cations of the general formula [(η⁶-arene)RuCl(dpqMe₂)]⁺ (dpqMe₂ = 6,7-dimethyl-2,3-di(pyridine-2-yl)quinoxaline; arene = C₆H₆, 1; C₆H₅Me, 2; p-PrⁱC₆H₄Me, 3; C₆Me₆, 4) as well as the dinuclear dications [(η⁶-arene)₂Ru₂Cl₂(μ-dpqMe₂)]²⁺ (arene = C₆H₆, 5; C₆H₅Me, 6; p-PrⁱC₆H₄Me, 7; C₆Me₆, 8) have been synthesised from 6,7-dimethyl-2,3-di(pyridine-2-yl)quinoxaline (dpqMe₂) and the corresponding chloro complexes [(η⁶-C₆H₆)Ru(μ-Cl)Cl]₂, [(η⁶-C₆H₅Me)Ru(μ-Cl)Cl]₂, [(η⁶-p-PrⁱC₆H₄Me)Ru(μ-Cl)Cl]₂ and [(η⁶-C₆Me₆)Ru(μ-Cl)Cl]₂, respectively. The X-ray crystal structure analyses of [1][PF₆], [3][PF₆] and [6][PF₆]₂ reveal a typical piano-stool geometry around the metal centre; in the dinuclear complexes the two chloro ligands, with respect to each other, are found to be trans oriented.     

Synthesis,characterisation and biological activity of cycloaurated organogold(III) complexes with imidate ligands

The reactions of the cycloaurated gold(III) complexes (2-bp)AuCl₂ (2-bp = 2-benzylpyridyl) or (damp)AuCl₂ (damp = Me₂NCH₂C₆H₄) with an excess of sodium saccharinate (Nasacc), potassium phthalimidate (Kphth), or with isatin and trimethylamine in refluxing methanol results in the successful isolation of a series of new gold(III) imidate complexes. These were characterised by NMR and IR spectroscopies, and by X-ray structure determinations on (2-bp)Au(sacc)₂ and (2-bp)Au(phth)₂. In both structures, the planes of the saccharinate and the phthalimidate ligands are orientated almost perpendicular to the gold coordination plane. As expected from trans-influence considerations, the Au–N_(imidate) bond lengths trans to the aryl carbon atoms are longer than the Au–N_(imidate) bond lengths trans to the pyridyl groups. The complexes have also been characterised by electrospray ionisation MS; in the presence of halide ligands, one imidate ligand is readily displaced. Anti-tumour (P388 murine leukemia) and selected anti-microbial data for the new complexes are reported. Surprisingly, all three damp complexes had low anti-tumour activity, which is likely to be a consequence of the poor solubility of these complexes. The synthesis and characterisation of a related gold(III) bis(amidate) complex derived from sulfathiazole is also described.     

Three new pseudohalide bridged dinuclear Zn(II) Schiff base complexes: Synthesis,crystal structures and fluorescence studies

Three new dinuclear Zn(II) complexes [Zn(L)(μ_1,1-N₃)Zn(L)(N₃)] · 1.5H₂O (1), [Zn(L)(μ_1,1-NCO)Zn(L)(NCO)] · 1.5H₂O (2) and [Zn(L)(μ_1,1-NCS)Zn(L)(NCS)(OH₂)] (3) have been synthesized from a potentially tetradentate N₂O₂-donor Schiff base ligand LH, [LH = (OCH₃)(OH)C₆H₃CHN(CH₂)₂N(CH₃)₂], which is the condensation product of o-vanillin and 2-dimethylaminoethylamine. All the three complexes 1, 2 and 3 have been characterized by elemental analysis, IR and ¹H NMR spectroscopy, TGA and fluorescence studies. Finally, their structures have been established by the single crystal X-ray diffraction method. Structural studies reveal that in complexes 1, 2 and 3 the two Zn(II) centers are held together by a μ₂-phenolato oxygen atom and also by an end-on pseudohalide nitrogen (azide for 1; cyanate for 2; thiocyanate for 3) atom. Among the two deprotonated Schiff base ligands present in each complex, one acts as a tetradentate ligand (N₂O₂ donor set) while the other acts as a tridentate ligand (N₂O donor set), having a non-coordinated methoxy group. All the synthesized complexes display intraligand ¹(π–π^∗) fluorescence and can potentially serve as photoactive materials.     

Platinum(II) complexes containing the 3,3-dimethylglutarimidate ligand

Reaction of cis-[PtCl₂(PPh₃)₂] with excess 3,3-dimethylglutarimide (dmgH) and sodium chloride in refluxing methanol gives the mono-imidate complex cis-[PtCl(dmg)(PPh₃)₂], which was structurally characterized. The plane of the imidate ligand is approximately perpendicular to the platinum coordination plane which, coupled with restricted rotation about the Pt–N bond, results in inequivalent methyl groups and CH₂ protons of the dmg ligand in the room temperature ¹H NMR spectrum. These observations were corroborated by a theoretical study using density functional theory methods. The analogous bromide complex cis-[PtBr(dmg)(PPh₃)₂] can be prepared by replacing NaCl with NaBr in the reaction mixture.